Mary Tyler Moore Surprises Everyone on Rachael Ray Show

alt text

(Best Syndication News) Mary Tyler Moore and Dick Van Dyke were on the Rachael Ray show discussing their antics on The Dick Van Dyke Show. Van Dyke was reminiscing about the first time they met when the 74-year old Moore made a surprise entrance.

They recreated the 1970s set and reminisced. Van Dyke said that he might have been a little in-love with Moore back when they were on the show; but in those days they didn’t act on their mutual attraction.

The star of “Ordinary People” was rumored to have a benign tumor called meningioma. Back in July of 2007, the Globe broke the story. Moore’s representative now tells People Magazine that the star will undergo surgery to remove the growth. They are calling the procedure “fairly routine.”

Dr Oz Discusses Foods that Fight Cancer

alt text

(Best Syndication News) When people eat food they typically think about the calories, but they should also think about the cancer prevention benefits of the food too. On Thursday Dr. Oz told his audience that certain foods can help prevent cancer.

The National Institutes of Health (NIH) found studies that support some of the claims made on the Dr Oz show. Men who ate carotenoid lycopene, which is found in tomatoes, could reduce their risk of some of the more deadly forms of prostate cancer. “Five studies support a 30% to 40% reduction in risk associated with high tomato or lycopene consumption”, the NIH concluded.

Metastatic Prostate Cancer – Zytiga medication (abiraterone acetate) gets FDA approval

prescription medication

(Best Syndication News) - The US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate) medication along with prednisone (a steroid) for the treatment of late-stage metastatic prostate cancer. Zytiga is marketed by Centocor Ortho Biotech Inc.

Zytiga is a once daily pill that helps to decrease testosterone levels in those patients that have not been able to with other treatments. The abirateron acetate drug targets a protein called cytochrome P450 17A1 (CYP17A1), which is known to create the testosterone hormone. By reducing the hormones it would slow the cancer cell growth.

Zytiga gained FDA approval ahead of the June 20, 2011 regulatory goal date. The clinical study of 1,195 patients that had late-stage castration-resistant prostate cancer and also had previously received treatment with docetaxel chemotherapy were studied with either Zytiga one per day along with prednisone twice each day or the other group was given a placebo (sugar pill) two times per day along with the prednisone treatment.

Thyroid Cancer Treatment Vandetanib gets FDA Approval

Thyroid Cancer Treatment Vandetanib gets FDA Approval

Best Syndication News

(Best Syndication News) - The US Food and Drug Administration (FDA) approved a daily medication called vandetanib used to treat late-stage medullary thyroid cancer for adults. This is a treatment that could be used only if surgery wasn't an option and if the thyroid cancer was causing symptoms. Vandetanib is being marketed by AstraZeneca Pharmaceuticals LP.

The National Cancer Institute estimates that around 44,600 people are newly diagnosed with thyroid cancer in the United States each year. Out of these around 1,690 died from thyroid cancer in 2010. Medullary thyroid cancer is a more rare form of all of the different kinds of thyroid cancer and only is seen in around 3 to 5 percent of all the diagnosis. Roughly 1,300 to 2,200 patients were diagnosed with medullary thyroid cancer in 2010.

Melanoma skin cancer treatment approved by FDA

(Best Syndication News) - Yervoy (ipilimumab) which is marketed by New York City-based Bristol-Myers Squibb gained the US Food and Drug (FDA) approval for treatment of late-stage metastatic melanoma skin cancer. Melanoma is the deadliest form of skin cancer according to the National Cancer Institute. In 2010, there were around 8,700 people that died from melanoma skin cancer.

Yervoy is the first therapy treatment to show that it has extended the life of people diagnosed with last-stage melanoma and to be approved by the FDA. The Yervoy drug treatment is given intravenously.

Syndicate content


Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved